Skip to main
CING
CING logo

Cingulate (CING)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Cingulate (CING) Stock

About Cingulate (CING)

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future pr...read more
Market cap$17.83M
Today's volume99.72K
Revenue (TTM)
Avg. daily volume145.61K
EBITDA (TTM)-$15.75M
Open$4.20
Price / earnings ratio-0.41x
Today's range$4.2 - $4.49
Debt / equity85.68x
52 week range$1.8 - $20.83
5 year debt / equity26.78x
Beta (LTM)0.82x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio1.87x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

Cingulate Stock Rating

What analysts recommend for CING stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for Cingulate stock is $17.84M

The current P/E ratio for Cingulate stock is -0.41

The 52-week high for Cingulate stock is $20.83. The current Cingulate stock price $undefined is 100.00% below its 52-week high

The 52-week low for Cingulate stock is $1.80. The current Cingulate stock price $undefined has increased 100.00% from its 52-week low

No, the Cingulate stock does not pay dividends to its shareholders

The target price for Cingulate stock is $17.79 based on the average of what a group of analyst think Cingulate stock could be worth at a future date. This is not a prediction by Public.com

How to buy Cingulate stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Cingulate stock

    Navigate to the Explore page. Then, type Cingulate into the search bar. When you see Cingulate stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Cingulate stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Cingulate Stock Earnings

The value each CING share was expected to gain vs. the value that each CING share actually gained.

Cingulate (CING) reported Q1 2025 earnings per share (EPS) of -$1.04, missing estimates of -$0.96 by 8.33%. In the same quarter last year, Cingulate's earnings per share (EPS) was -$7.20. Cingulate is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of $0.

Buy Cingulate (CING) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.